Combining Hydroxyzine and Codeine: Safety and Recommendations
Hydroxyzine can be combined with codeine, but the codeine dose must be reduced due to hydroxyzine's potentiating effect on central nervous system (CNS) depressants, and this combination should be used with caution given additive sedation and respiratory depression risks. 1
Critical FDA Warning
The FDA drug label explicitly states that "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS NARCOTICS" and mandates that "when central nervous system depressants are administered concomitantly with hydroxyzine their dosage should be reduced." 1 This is not optional guidance—it is a direct safety requirement.
Key Safety Considerations
CNS Depression and Respiratory Risk
- Hydroxyzine causes additive respiratory depression with opioids that is NOT reversible with naloxone 2
- Both agents cause significant drowsiness and sedation
- The combination increases risk of over-sedation, particularly in elderly patients 1
- Patients must be warned against driving or operating machinery 1
Cardiac Risks
Hydroxyzine carries risk of QT prolongation and Torsade de Pointes 1. This combination should be avoided or used with extreme caution in patients with:
- Pre-existing heart disease
- Electrolyte imbalances
- Concomitant use of other QT-prolonging medications
- Recent myocardial infarction
- Uncompensated heart failure
- Bradyarrhythmias
Genetic Considerations for Codeine
Codeine should be avoided entirely in CYP2D6 ultrarapid metabolizers (risk of toxicity) and poor metabolizers (lack of efficacy) 3, 4. Consider pharmacogenetic testing if concerns about toxicity or lack of response exist 3.
Dosing Recommendations
Codeine Dosing
Standard codeine dosing is 30-60 mg every 4-6 hours 5, 6. When combined with hydroxyzine, start at the lower end (30 mg) and reduce further if needed based on the FDA mandate to decrease opioid doses when combined with hydroxyzine 1.
Hydroxyzine Dosing
- Typical adult dose: 25-100 mg
- Start at lower doses (25-50 mg) in elderly patients 1
- Research showing analgesic potentiation used 100 mg hydroxyzine with morphine 7, but this resulted in significantly more drowsiness
Clinical Evidence on Efficacy
The evidence for hydroxyzine as an opioid adjuvant is weak and contradictory:
- One 1980 study found that 100 mg hydroxyzine combined with 10 mg morphine provided superior analgesia to morphine alone, but with significantly more drowsiness 7
- A 1983 study with meperidine showed only additive analgesia during the first 2 hours, with the conclusion that "the limited additive analgesia observed with the addition of meperidine to hydroxyzine does not justify the added toxicity of the narcotic" 8
- A 1990 systematic review concluded that "the data do not confirm the purported clinical benefits of hydroxyzine-opioid combinations in comparison with appropriate regimens of opioids alone" and noted serious methodologic flaws in supporting studies 2
Practical Algorithm for Use
Step 1: Assess Contraindications
- QT prolongation or cardiac risk factors → Do not combine
- Known CYP2D6 ultrarapid or poor metabolizer → Avoid codeine entirely 3
- Elderly or frail patient → Use extreme caution, start lowest doses
Step 2: If Proceeding with Combination
- Start codeine at 30 mg (not 60 mg) every 6 hours as needed
- Start hydroxyzine at 25-50 mg (not 100 mg)
- Reduce codeine dose by 25-50% from what you would use alone 1
Step 3: Monitor Closely
- Assess for excessive sedation within first 2 hours
- Monitor respiratory rate
- Warn patient about driving/machinery restrictions 1
- Avoid alcohol and other CNS depressants 1
Step 4: Consider Superior Alternatives For acute pain, evidence supports:
- NSAIDs (ibuprofen, naproxen) are superior to codeine-acetaminophen combinations with NNT of 2.7 vs 4.4 9
- Oxycodone-acetaminophen is marginally superior to codeine-acetaminophen 9
- Hydromorphone may be preferable to codeine for moderate-severe pain 9
Common Pitfalls to Avoid
- Using standard opioid doses: The FDA explicitly requires dose reduction—failure to do so increases toxicity risk
- Ignoring cardiac history: QT prolongation risk is real and documented 1
- Assuming analgesic benefit: The evidence for hydroxyzine potentiation is weak 2
- Overlooking CYP2D6 status: Codeine is a prodrug requiring CYP2D6 metabolism 3, 4
- Prescribing to elderly without dose adjustment: Start low, monitor closely 1
Bottom Line
While this combination is not absolutely contraindicated, the risk-benefit ratio is unfavorable. The modest and questionable analgesic benefit does not justify the increased sedation, respiratory depression, and cardiac risks. Consider NSAIDs or alternative opioids (oxycodone, hydromorphone) instead 9. If you must use this combination, reduce the codeine dose by at least 25-50%, start hydroxyzine at 25-50 mg, and monitor closely for CNS and cardiac adverse effects.